Grants and Contributions

This funding opportunity is expected to:
•Catalyze patient-oriented research aligned with the SPOR Patient Engagement Framework and SPOR Capacity Development Framework by:
¿Developing partnerships amongst patients and patient communities, researchers, health care professionals and health system decision-makers or policy-makers;
¿Mobilizing the above partnerships to develop and conduct a patient-oriented research project or projects; and,
¿Informing future applications for more comprehensive patient-oriented research grants.

This funding opportunity is expected to:

• Advance knowledge through the analysis of existing cohorts, data platforms and/or administrative datasets specific to one of the research areas above.

The objective of this funding opportunity is to catalyze and support research efforts of Canadian researchers to use the available CLSA data in order to better understand how (individually and in combination) the biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact in both maintaining health and in the development of disease and disability as people age.

This funding opportunity seeks to support world-class research on dementia, contributing to the global pursuit of finding a cure or disease-modifying treatment for dementia by 2025.

The Understanding Disease Prevention and Risk Factor Modification Catalyst Grants are expected to:

• increase our understanding of factors that enable individuals to adopt or overlook known disease risk modification strategies;
• expand the evidence and further understanding that can lead to future intervention studies in prevention; and
• develop a knowledge base upon which to nuance evidence-based policy to improve the prevention of manageable diseases.

The specific objectives of this funding opportunity are to:
1.Provide women’s health researchers and trainees with operating funds to perform clinical research;
2.Support capacity building in women’s health among the next generation of health researchers; and
3.Start positioning Canada as a leader in women’s health research.

This funding opportunity is expected to:
•Catalyze patient-oriented research aligned with the SPOR Patient Engagement Framework and SPOR Capacity Development Framework by:
¿Developing partnerships amongst patients and patient communities, researchers, health care professionals and health system decision-makers or policy-makers;
¿Mobilizing the above partnerships to develop and conduct a patient-oriented research project or projects; and,
¿Informing future applications for more comprehensive patient-oriented research grants.

The funding opportunity Catalyst Grant: HIV/AIDS Community-Based Research is expected to:
•Support partnerships between communities affected by HIV and other STBBI in Canada and researchers to facilitate the conduct of CBR; and/or
•Develop future applications for more comprehensive CBR grants in the area of HIV and other STBBI in Canada.

• The CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) will provide funding for an application determined to be relevant to the broad INMD mandate as described below:
o CIHR-INMD supports research to enhance health in relation to diet, digestion, excretion, and metabolism; and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions and problems associated with hormone, digestive system, kidney, and liver.
• These grants afford principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees.

• The CIHR Institute of Infection and Immunity (CIHR-III) will offer funding for an application determined to be specifically relevant to CIHR-III broad mandate as described below:
o The Institute of Infection and Immunity (III) supports research and helps to build research capacity in the areas of infectious disease and the body's immune system.